Nea Management Company, LLC Addex Therapeutics Ltd. Transaction History

Nea Management Company, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.52 - $0.99 $2.84 Million - $5.41 Million	-5,468,690 Reduced 96.81%	180,000 $93,000
Q1 2023 May 15, 2023	BUY	$0.68 - $2.19 $3.11 Million - $10 Million	4,568,690 Added 423.03%	5,648,690 $5.37 Million
Q4 2022 Feb 10, 2023	SELL	$0.55 - $18.0 $2.51 Million - $82.2 Million	-4,568,690 Reduced 80.88%	1,080,000 $680,000
Q3 2022 Nov 14, 2022	BUY	$0.78 - $16.4 $3.67 Million - $77.2 Million	4,707,242 Added 500.0%	5,648,690 $830,000
Q2 2022 Aug 15, 2022	BUY	$1.05 - $5.35 $799,520 - $4.07 Million	761,448 Added 423.03%	941,448 $1.08 Million
Q2 2021 Aug 02, 2021	BUY	$8.91 - $11.25 $1.6 Million - $2.03 Million	180,000 New	180,000 $17.2 Million

Ticker ADXN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,204,630
Market Cap $61.8M
Description
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs includ...

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Nea Management Company, LLC with notifications on news.